(Q30981999)

28 June 2017

1 reference

title

MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update (English)

1 reference

28 June 2017

0 references

M P Wattjes

1

1 reference

28 June 2017

M D Steenwijk

series ordinal

2

1 reference

28 June 2017

M Stangel

series ordinal

3

1 reference

28 June 2017

language of work or name

1 reference

23 July 2015

1 reference

28 June 2017

Clinical neuroradiology

1 reference

28 June 2017

25 Suppl 2

1 reference

28 June 2017

157-165

1 reference

Creative Commons Attribution 4.0 International

28 June 2017

start time

23 July 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00062-015-0430-y

0 references

cites work

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

The investigation of acute optic neuritis: a review and proposed protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

The clinico-radiological paradox in multiple sclerosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Measurement and clinical effect of grey matter pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Postmortem verification of MS cortical lesion detection with 3D DIR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Inflammation high-field magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Brainstem lesions in clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Clinical relevance of brain volume measures in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

What explains gray matter atrophy in long-standing multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Imaging outcomes for trials of remyelination in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Natalizumab: bench to bedside and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

MRI pattern in asymptomatic natalizumab-associated PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Tumefactive multiple sclerosis lesions under fingolimod treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Measures in the first year of therapy predict the response to interferon β in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00062-015-0430-Y

Treatment optimization in MS: Canadian MS Working Group updated recommendations.

21 January 2018

1 reference

12 December 2020

What drives MRI-measured cortical atrophy in multiple sclerosis?

1 reference

12 December 2020

PML in a patient treated with dimethyl fumarate from a compounding pharmacy

1 reference

12 December 2020

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

12 December 2020

Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome

1 reference

12 December 2020

Does high field MRI allow an earlier diagnosis of multiple sclerosis?

1 reference

12 December 2020

Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis

1 reference

12 December 2020

10.1007/S00062-015-0430-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

0 references

1 reference